Novartis Investigative Site

Ichikawa, Chiba 2728516

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Polymyalgia Rheumatica

Studies at this site

• Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) — Completed
• Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab — Stopped early